In vitro experiments verified that the T2DM microenvironment inhibited the expression of GPX4 and SLC7A11, while elevating inflammatory factor levels in alveolar osteocytes, leading to cellular ferroptosis [26]. Here, SLC7A11 is linked to type 2 diabetes mellitus.